Pfizer Inc., 10% Owner at Celladon Corp (CLDN), bought 1,794,803 shares at $8.00 ($2.0M) on 2014-02-04, disclosed to the SEC on 2014-02-06.
Open-market purchase of $2.0M CLDN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,544,397 | $0 | 0.0% |
| 2 | $8.00 | 23,145 | $185K | 9.2% |
| 3 | $8.00 | 227,261 | $1.8M | 90.8% |
| Total | $1.12 avg | 1,794,803 | $2.0M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $900K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $1.0M | — | Filing → |
| RYTM | BUY | 2017-10-10 | $680K | — | Filing → |